BioTheranostics' Series A Round

BioTheranostics raised a round of funding on January 21, 2016.

bioTheranostics specializes in helping physicians improve the care of cancer patients, offering a suite of proprietary molecular diagnostic tests that allow treatment to be tailored to individual pati…

Articles about BioTheranostics' Series A Round: